Upregulated AHIF-mediated radioresistance in glioblastoma

Biochem Biophys Res Commun. 2019 Feb 5;509(2):617-623. doi: 10.1016/j.bbrc.2018.12.136. Epub 2018 Dec 31.

Abstract

Long non-coding RNAs (lncRNAs) play vital roles in the pathobiology of glioblastoma multiforme (GBM). Though radiotherapy remains the most effective component of multiple therapies for patients with GBM, lncRNAs conferring GBM radioresistance are less unknown. Here, the present study identified that the antisense transcript of hypoxia-inducible factor-1α (AHIF) was upregulated in GBM cells after radiotherapy. The deregulation of AHIF affected GBM cell clonogenic formation, DNA repair and apoptosis. Notably, knockdown of AHIF inhibited tumorigenesis after radiotherapy in vivo. Further biochemical analysis identified that AHIF regulated proteins associated with apoptosis after radiotherapy. Thus, the present data illustrate that suppression of AHIF increases radiosensitivity in GBM cells, which may be a potential diagnostic and therapeutic target for GBM patients.

Keywords: AHIF; Apoptosis; Glioblastoma; Radiotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / radiation effects
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / radiotherapy*
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic / radiation effects
  • Glioblastoma / genetics*
  • Glioblastoma / radiotherapy*
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics*
  • Mice
  • RNA, Long Noncoding / genetics*
  • Radiation Tolerance
  • Up-Regulation* / radiation effects

Substances

  • Hypoxia-Inducible Factor 1, alpha Subunit
  • RNA, Long Noncoding